Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Acquired Immunologic Neuropathies.
Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms.
Disease-related and functional predictors of employment status among adults with multiple sclerosis.
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.
Caregiving in multiple sclerosis.
There is much to be learnt about the costs of multiple sclerosis in Latin America.
Epstein-Barr virus in oral shedding of children with multiple sclerosis.
Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their health.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
3D+t Brain MRI segmentation using robust 4D Hidden Markov Chain.
Effects of a Tailored Positive Psychology Intervention on Well-being and Pain in Individuals with Chronic Pain and a Physical Disability: A Feasibility Trial.
Fatigue in multiple sclerosis: a look at the role of poor sleep.
Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Reply to Letter to the Editor re: Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocy
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.]
Pages
« first
‹ previous
…
646
647
648
649
650
651
652
653
654
…
next ›
last »